Enavate Sciences is committed to invest in and support the strategic growth of innovative therapeutic and enabling technology companies.
Enavate Sciences has raised $300.0M in total funding. The most recent round was Private Equity. The last funding was announced in May 2022.
Enavate Sciences's investors include Patient Square Capital.
Enavate Sciences is headquartered in New York, United States.
Enavate Sciences is committed to invest in and support the strategic growth of innovative therapeutic and enabling technology companies.
Enavate Sciences is at the Private Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Enavate Sciences — Funding & Investors." VCBacked, May 2, 2022, https://www.vcbacked.co/company/enavate-sciences. Accessed August 14, 2026.
VCBacked. (2022). Enavate Sciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/enavate-sciences
{{cite web |title=Enavate Sciences — Funding & Investors |url=https://www.vcbacked.co/company/enavate-sciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated